Go to content
UR Home

TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma

Albert, Nathalie L., Unterrainer, M., Fleischmann, D. F., Lindner, S., Vettermann, F., Brunegraf, A., Vomacka, L., Brendel, M., Wenter, V., Wetzel, C. , Rupprecht, R., Tonn, J.-C., Belka, C., Bartenstein, P. and Niyazi, M. (2017) TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma. European Journal of Nuclear Medicine and Molecular Imaging 44 (13), pp. 2230-2238.

Full text not available from this repository.

at publisher (via DOI)

Other URL: http://doi.org/10.1007/s00259-017-3799-9


Abstract

Objective The 18-kDa mitochondrial translocator protein (TSPO) was reported to be upregulated in gliomas. F-18-GE-180 is a novel 3rd generation TSPO receptor ligand with improved target-to-background contrast compared to previous tracers. In this pilot study, we compared PET imaging with F-18-GE-180 and MRI of patients with untreated and recurrent pretreated glioblastoma. Methods Eleven patients ...

plus


Export bibliographical data



Item type:Article
Date:2017
Institutions:Medicine > Lehrstuhl für Psychiatrie und Psychotherapie
Identification Number:
ValueType
10.1007/s00259-017-3799-9DOI
Keywords:POSITRON-EMISSION-TOMOGRAPHY; BENZODIAZEPINE-BINDING-SITES; NEWLY-DIAGNOSED GLIOBLASTOMA; 18 KDA TSPO; TRANSLOCATOR PROTEIN; F-18-FET PET; MICROGLIAL ACTIVATION; GRADE GLIOMA; HUMAN BRAIN; IN-VIVO; Glioma; F-18-GE-180; TSPOPET; Radiotherapy planning
Dewey Decimal Classification:100 Philosophy & psychology > 150 Psychology
Status:Published
Refereed:Yes, this version has been refereed
Created at the University of Regensburg:Yes
Item ID:39540
Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons